NAOS YARON enters PROTALIX BIOTHERAPEUTICS, INC. with 199.56K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 6/8/2018ACC: 0001144204-18-033545
Officer· Sr. VP, Operations
Since Sep 2018
199.56K
Baseline shares
36% direct
71.13K
Direct ownership
1 position
215K
Derivative underlying
3 instruments
2
Security positions
128.44K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned71.13K
Common Stock
IndirectShares owned128.44K
Total
71.13K direct·128.44K indirect199.56K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 71.13K | Direct |
| Common Stock | 128.44K | Indirect |
| Total | 199.56K | 71.13K direct·128.44K indirect |
Derivative Holdings3
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
115K
Shares owned
N/A
Exercise price
6.90
Expiration
—
Exercise window
—
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
2.65
Expiration
—
Exercise window
—
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
1.72
Expiration
—
Exercise window
—
Total
Underlying
215K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock | 6.90 | — | — | 115K | N/A |
| Stock Options (Right to Buy) Direct | Common Stock | 2.65 | — | — | 50K | N/A |
| Stock Options (Right to Buy) Direct | Common Stock | 1.72 | — | — | 50K | N/A |
| Total | 215K | 0.00 | ||||